Success Metrics

Clinical Success Rate
90.6%

Based on 29 completed trials

Completion Rate
91%(29/32)
Active Trials
4(9%)
Results Posted
34%(10 trials)
Terminated
3(7%)

Phase Distribution

Ph phase_2
6
13%
Ph phase_3
1
2%
Ph early_phase_1
1
2%
Ph not_applicable
28
62%
Ph phase_4
2
4%
Ph phase_1
1
2%

Phase Distribution

2

Early Stage

6

Mid Stage

3

Late Stage

Phase Distribution39 total trials
Early Phase 1First-in-human
1(2.6%)
Phase 1Safety & dosage
1(2.6%)
Phase 2Efficacy & side effects
6(15.4%)
Phase 3Large-scale testing
1(2.6%)
Phase 4Post-market surveillance
2(5.1%)
N/ANon-phased studies
28(71.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.3%

29 of 34 finished

Non-Completion Rate

14.7%

5 ended early

Currently Active

4

trials recruiting

Total Trials

45

all time

Status Distribution
Active(4)
Completed(29)
Terminated(5)
Other(7)

Detailed Status

Completed29
unknown7
Recruiting3
Terminated3
Withdrawn2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
45
Active
4
Success Rate
90.6%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (2.6%)
Phase 11 (2.6%)
Phase 26 (15.4%)
Phase 31 (2.6%)
Phase 42 (5.1%)
N/A28 (71.8%)

Trials by Status

active_not_recruiting12%
withdrawn24%
completed2964%
recruiting37%
unknown716%
terminated37%

Recent Activity

Clinical Trials (45)

Showing 20 of 45 trialsScroll for more
NCT01907789Not Applicable

Prophylactic Salpingectomy With Delayed Oophorectomy

Active Not Recruiting
NCT04715685Not Applicable

Mind Body Balance for Pediatric Migraine

Recruiting
NCT06555107Not Applicable

Acute Preoperative Pain and Chronic Post-surgical Pain in Emergency Surgery

Recruiting
NCT01927744Phase 2

Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection

Completed
NCT05793541Not Applicable

Just-in-time Interventions for Reducing Short-term Suicide Risk

Recruiting
NCT06805383Not Applicable

Randomized Trial of Follow-up to Mailed FIT Kits

Completed
NCT06982430

Early Recurrence of Renal Colic: Predictive Factors

Completed
NCT05910229Not Applicable

Telephone Paramedical Support Prior to the Radiotherapy Simulation Scanner for Patients with Prostate Cancer

Completed
NCT05964842Not Applicable

Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda

Completed
NCT03813537Not Applicable

Evaluation of Hospital Readmission Rate Dependent on Post-Operative Follow-Up Procedure

Completed
NCT06079229

Quality of Life in Elderly Patients After Pancreatic Cancer Surgery

Completed
NCT02385110Phase 2

Alemtuzumab or Tocilizumab in Combination With Etoposide and Dexamethasone for the Treatment of Adult Patients With Hemophagocytic Lymphohistiocytosis

Completed
NCT05613244

Descriptive Study of a Cohort of Orbital Solitary Fibrous Tumors

Completed
NCT06046807

Long-Term Post Thrombotic Syndrome Assessment (CELEST Long Term).

Unknown
NCT05977062Not Applicable

Optimization of an Online Stepwise Therapeutic Device Based on a Cognitive-behavioral Approach for Cancer Patients With Insomnia

Unknown
NCT04376476Not Applicable

Host-pathogen Interactions During SARS-CoV-2 Infection

Completed
NCT04834726Not Applicable

COVID-19 Vaccine Text Outreach

Completed
NCT05778240Not Applicable

Adherence to Palivizumab Prophylaxis

Completed
NCT03706963Not Applicable

Remote Telemonitoring to Improve Prehabilitation and Surgical Outcomes of Patients Undergoing Elective Abdominal Surgery

Terminated
NCT04470869Not Applicable

Impact on the OLAF Intervention to Prevent Post Traumatic Disorders During the Confinement.

Completed

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
45